XML 48 R38.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Segment and Geographic Information (Tables) | 6 Months Ended
--- | ---
Mar. 31, 2024
Segment Reporting [Abstract] |
Schedule of financial information for reportable segments | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Three Months Ended March 31, | ​ | Six Months Ended March 31,
​ | ​ | ​ | 2024 | ​ | 2023 | ​ | 2024 | ​ | 2023
Revenue: |  | ​ | ​ | ​ | ​ | ​ |  |  | ​ |  |  | ​ |
Sample Management Solutions | ​ | ​ | $ | 74,137 | ​ | $ | 71,043 | ​ | $ | 153,142 | ​ | $ | 146,498
Multiomics | ​ | ​ |  | 62,218 | ​ |  | 62,236 | ​ |  | 124,938 | ​ |  | 123,325
B Medical Systems | ​ | ​ | ​ | 22,779 | ​ | ​ | 15,122 | ​ | ​ | 35,371 | ​ | ​ | 56,944
Total revenue | ​ | ​ | $ | 159,134 | ​ | $ | 148,401 | ​ | $ | 313,451 | ​ | $ | 326,767
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Adjusted operating loss: | ​ | ​ |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​
Sample Management Solutions | ​ | ​ | $ | (1,567) | ​ | $ | (6,076) | ​ | $ | (2,423) | ​ | $ | (9,074)
Multiomics | ​ | ​ |  | (2,966) | ​ |  | (3,810) | ​ |  | (6,417) | ​ |  | (7,075)
B Medical Systems | ​ | ​ | ​ | (1,153) | ​ | ​ | (3,367) | ​ | ​ | (5,562) | ​ | ​ | 2,936
Segment adjusted operating loss | ​ | ​ | ​ | (5,686) | ​ | ​ | (13,254) | ​ | ​ | (14,402) | ​ | ​ | (13,213)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amortization of completed technology | ​ | ​ | ​ | 6,373 | ​ | ​ | 4,901 | ​ | ​ | 12,000 | ​ | ​ | 9,070
Purchase accounting impact on inventory | ​ | ​ | ​ | — | ​ | ​ | 2,912 | ​ | ​ | — | ​ | ​ | 5,781
Amortization of intangible assets other than completed technology | ​ | ​ | ​ | 6,654 | ​ | ​ | 7,509 | ​ | ​ | 13,516 | ​ | ​ | 14,882
Transformation costs(1) | ​ | ​ | ​ | 4,446 | ​ | ​ | 10 | ​ | ​ | 4,487 | ​ | ​ | (55)
Restructuring charges | ​ | ​ | ​ | 7,344 | ​ | ​ | 1,499 | ​ | ​ | 8,464 | ​ | ​ | 2,961
Impairment of goodwill and intangible assets | ​ | ​ | ​ | 115,975 | ​ | ​ | — | ​ | ​ | 115,975 | ​ | ​ | —
Contingent consideration - fair value adjustments | ​ | ​ | ​ | — | ​ | ​ | (17,145) | ​ | ​ | — | ​ | ​ | (17,145)
Merger and acquisition costs and costs related to share repurchase(2) | ​ | ​ | ​ | 426 | ​ | ​ | 19 | ​ | ​ | 4,747 | ​ | ​ | 11,857
Other unallocated corporate expenses | ​ | ​ | ​ | 51 | ​ | ​ | 18 | ​ | ​ | 41 | ​ | ​ | 98
Total operating loss | ​ | ​ | ​ | (146,955) | ​ | ​ | (12,977) | ​ | ​ | (173,632) | ​ | ​ | (40,662)
Interest income, net | ​ | ​ | ​ | 9,565 | ​ | ​ | 10,394 | ​ | ​ | 19,646 | ​ | ​ | 21,059
Other income (expense), net | ​ | ​ | ​ | 250 | ​ | ​ | (2,668) | ​ | ​ | 932 | ​ | ​ | (1,523)
Loss before income taxes | ​ | ​ | $ | (137,140) | ​ | $ | (5,251) | ​ | $ | (153,054) | ​ | $ | (21,126)
| (1) | Transformation costs represent non-recurring expenses for strategic projects with anticipated long-term benefits to the Company focused on cost reduction and productivity improvement that do not meet the definition of restructuring charges. These costs are directed at simplifying, standardizing, streamlining, and optimizing the Company’s operations, processes and systems to permanently alter the Company’s operations for the long term. For a project to be considered transformational, successful completion of the project must be expected to bring long-term material benefits to the organization and involve significant changes to process and/or underlying technology. Transformation costs in the period result from actions taken as part of the Company’s 2024 transformation plan, and primarily relate to one time asset write downs associated with changes in technology, one time inventory write downs relating to restructuring actions taken in the period, and third-party consulting costs associated with process & systems re-design.
| (2) | Includes expenses related to governance-related matters.
Schedule of reconciliation of reportable segment assets to corresponding consolidated amounts | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Assets: | ​ | ​ | March 31, 2024 | ​ | September 30, 2023 | ​
Sample Management Solutions | ​ | ​ | $ | 845,641 | ​ | $ | 675,708 | ​
Multiomics | ​ | ​ | ​ | 462,684 | ​ | ​ | 534,437 | ​
B Medical Systems | ​ | ​ | ​ | 248,880 | ​ | ​ | 511,640 | ​
Total assets | ​ | ​ | $ | 1,557,205 | ​ | $ | 1,721,785 | ​
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, |  | September 30,
​ | ​ | 2024 | ​ | 2023
Segment assets |  | $ | 1,557,205 |  | $ | 1,721,785
Cash and cash equivalents, restricted cash and marketable securities | ​ |  | 975,358 | ​ |  | 1,134,256
Deferred tax assets | ​ |  | 925 | ​ |  | 571
Other assets | ​ | ​ | 30,009 | ​ | ​ | 29,108
Total assets | ​ | $ | 2,563,497 | ​ | $ | 2,885,720
Schedule of revenue from external customers attributed to geographic areas | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, | ​ | Six Months Ended March 31,
​ |  | 2024 | ​ | 2023 | ​ | 2024 | ​ | 2023
Geographic Location: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
United States | ​ | $ | 88,398 | ​ | $ | 86,572 | ​ | $ | 178,990 | ​ | $ | 174,321
Africa | ​ | ​ | 18,942 | ​ | ​ | 8,627 | ​ | ​ | 26,453 | ​ | ​ | 25,837
China | ​ | ​ | 13,646 | ​ | ​ | 11,979 | ​ | ​ | 28,544 | ​ | ​ | 25,387
United Kingdom | ​ | ​ | 5,641 | ​ | ​ | 5,789 | ​ | ​ | 11,340 | ​ | ​ | 11,202
Rest of Europe | ​ | ​ | 23,850 | ​ | ​ | 21,432 | ​ | ​ | 48,682 | ​ | ​ | 60,854
Asia Pacific/Other | ​ | ​ | 8,657 | ​ | ​ | 14,002 | ​ | ​ | 19,442 | ​ | ​ | 29,166
Total revenue | ​ | $ | 159,134 | ​ | $ | 148,401 | ​ | $ | 313,451 | ​ | $ | 326,767

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration